H2-Receptor antagonist reduces food intake and weight gain in rats by non-gastric acid secretory mechanisms

Acta Physiologica Scandinavica

Volumn 161, Issue 4, 1997, Pages 489-494

  Stoa Birketvedt, G ^a,d   Lovhaug, N ^b   Vonen, B ^c   Florholmen, J ^a  

^a Institute of Clinical Medicine   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Appetite; Cimetidine; Famotidine; Obesity; Omeprazole; Ranitidine; Weight regulation

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; ANTIULCER AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; WEIGHT GAIN; ANIMAL; EATING; SECRETION; STOMACH ACID; WISTAR RAT;

ANIMALS; ANTI-ULCER AGENTS; CIMETIDINE; EATING; FAMOTIDINE; GASTRIC ACID; HISTAMINE H2 ANTAGONISTS; MALE; OMEPRAZOLE; RANITIDINE; RATS; RATS, WISTAR; WEIGHT GAIN;

EID: 0031308383     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1997.00249.x     Document Type: Article

References (24)

1. 2-receptor antagonist. J Int Med Res 3, 86-92.
2. 2-receptor antagonist. Br J Pharmacol 93, 69-78.
3. Cantu, T.G. & Korek, J.S. 1991. Central nervous system reactions to histamine-2 receptor blockers. Ann Int Med 114, 1027-1034.
4. Ekman, L., Hansson, E., Havu, N., Carlsson, E. & Lundberg, C. 1985. Toxicological studies on omeprazole. Scand J Gastroenterol 20, 53-69.
5. Gibbs, J., Young, R.C. & Smith, G.P. 1973 Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84, 488-493.
6. Hoebel, B.G. & Hernandez, L. 1993. Basic neural mechanisms of feeding and weight regulation. In: A. Srunkard & T. A. Wadden (eds) Obesity: theory and therapy, 2nd edn, pp. 43-62. Raven Press, New York.
7. Kagevi, I., Thorhallsson, E. & Wählby, L. 1987. CSF concentrations of famotidine. Br J Clin Pharmacol 24, 849-850.
8. Konturek, J.W., Konturek, S.J. & Domschke, W. 1995. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients. Scand J Gastroenterol 30, 738-744.
9. Larsson, H., Carlsson, F., Junggren, U., Olbe, L., Sjöstrand, S.E., Skånberg, I. & Sundell, G. 1983. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 85, 900-907.
10. Larsson, H., Mattson, H., Sundell, G. & Carlsson, E. 1985. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo. Scand J Gastroenterol 20, 23-35.
11. Leslie G.B. & Walker T.F. 1977 A toxicological profile of cimetidine. 1977. In: W.L. Burland & M.A. Simkins (eds) Cimetidine, pp. 24-37. Exerpta Medica, Amsterdam.
12. Pinson, D.M., Havu, N., Sztern, M.I., Mattsson, H., Looney, G.A., Kimler, B.F. & Hurwitz, A. 1995. Drug-induced hypergastrinemia: absence of trophic effects on colonic carcinoma in rats. Gastroenterology 108, 1068-1074.
13. 2-receptor antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia. Medicina Firenze 10, 294-296.
14. Saigenji, K., Fukutomi, H. & Nakazava, S. 1987. Famotidine: postmarketing clinical experience. Scand J Gastroenterol 134, 34-40.
15. 2-receptor antagonist famotidine in the rat: comparison with ranitidine. Br J Pharmacol 92, 153-159.
16. Schentag, J.J., Cerra, F.B., Calleri, G., DeGlopper, E., Rose, J.Q. & Bernhard, H. 1979. Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet, 177-181.
17. 2-receptor antagonists. Br J Pharmacol 94, 264-274.
18. Smith, G., Jerome, C., Cushin, B., Eterno, R. & Simansky, K. 1981. Abdominal vagotomy blocks the satiety effect of cholecystokinin in rats. Science 21, 1036-1037.
19. Sjödin, L. 1972. Influence of secretin and cholecystokinin on canine gastric secretion elicited by food and by exogenous gastrin. Acta Physiol Scand 85, 110-117.
20. Støa-Birketvedt, G. 1993. Effect of cimetidine suspension on appetite and weight in overweight subjects. Br Med J 306, 1091-1093.
21. Støa-Birketvedt, G., Paus, P., Gans, R. & Florholmen, J. 1996. Cimetidine reduces weight and improves metabolic control in type II diabetes mellitus. Diabetes 45, 122A.
22. Støa-Birketvedt, G., Waldum, H.L., Vonen, B. & Florholmen, J. 1997. Effect of cimetidine on basal and postprandial plasma concentrations of cholecystokinin and gastrin in man. Acta Phys Scand 159, 321-325.
23. 2-blocker, 3-[[2[(diaminomethylene)amino-4-thiazolyl]methyl]thio]-N2-sulfamoyl propionamidine (YM-11170) on gastric secretion, ulcer formation and weight of male accessory sex organs in rats. Arzneimittelforschung 32, 734-737.
24. Walan, A. & Strøm, M. 1985. Metabolic consequences of reduced gastric acidity. Scand J Gastroenterol 111, 24-30.